Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone and CBT for Alcoholism and PTSD
NCT00006489Phase 4Completed
- Sponsor
- University of Pennsylvania
- Start
- Dec 2000
- Primary completion
- Feb 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of naltrexone in alcohol dependence and post-traumatic stress disorder (PTSD) (4 arms), sponsored by University of Pennsylvania. Primary endpoints: Posttraumatic Stress Disorder Symptom Scale - Interview at 52 weeks and Drinking Timeline Follow-back Interview at 52 weeks. Started Dec 2000; status: completed.
02
Drugs
naltrexone
03
Conditions
alcohol dependencepost-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00006489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00006489.